Pilot Study of Cognitive Assessment in Welsh Speakers

Sponsor
Conor Martin (Other)
Overall Status
Unknown status
CT.gov ID
NCT02199782
Collaborator
Betsi Cadwaladr University Health Board (Other)
100
1
2
8
12.6

Study Details

Study Description

Brief Summary

19% of Wales' population speaks Welsh. Under the Welsh Language Act 1993, every public body providing services to the public in Wales has to prepare a scheme setting out how it will provide those services in Welsh.

Diagnosing dementia requires a comprehensive assessment, an essential component of which is a cognitive assessment tool, which takes the form of a questionnaire. In clinical practice, this is currently only available through the medium of English.

The investigators objective is to measure the difference between Cognitive Assessment scores (using the Montreal cognitive assessment (MoCA)), when done in English and Welsh, in those who are cognitively impaired and whose first language is Welsh. The investigators predict that there will be a significant difference in scores in favour of the Welsh-medium tests, thus proving that the current mode of administering the test is prejudiced against patients whose first language is Welsh.

If the investigators predictions are correct, then the investigators would seek to introduce a validated Welsh-language cognitive assessment tool to the domain of the Welsh NHS.

Condition or Disease Intervention/Treatment Phase
  • Other: Welsh language Cognitive Assessment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Pilot Study of Cognitive Assessment in Welsh Speakers
Study Start Date :
Feb 1, 2015
Anticipated Primary Completion Date :
Aug 1, 2015
Anticipated Study Completion Date :
Oct 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Welsh

Participants will complete the cognitive assessment in Welsh and in English these will be compared to assess whether first language Welsh speakers perform better in Welsh.

Other: Welsh language Cognitive Assessment
This intervention may intervene by displaying a more realisitic reflection of the patient's cognitive ability by assessing the patient in their first language

Active Comparator: English

Participants will complete the cognitive assessment in Welsh and in English these will be compared to assess whether first language Welsh speakers perform better in Welsh.

Other: Welsh language Cognitive Assessment
This intervention may intervene by displaying a more realisitic reflection of the patient's cognitive ability by assessing the patient in their first language

Outcome Measures

Primary Outcome Measures

  1. Difference in Cognitive Assessment Score between Welsh and English [at 0 and 48 hrs]

Secondary Outcome Measures

  1. To measure the differences between participants' scores in Welsh and English and compare between different types of Dementia [0 and 48hrs]

    We will records each participant's type of cognitive decline - e.g. Alzheimer's, Vascular, Frontal, Lewy Body, etc, and compare the differences in scores - to see whether different types of dementia will perform significantly worse or better in their first and second languages (Welsh and English).

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Welsh Speakers - self-identify as first-language Welsh

  • Diagnosis of Dementia - recorded in patient's case notes

Exclusion Criteria:
  • Refusal

  • Intercurrent illness

  • Blind/any other disability which may prevent participant from fully completing Cognitive Assessment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ysbyty Glan Clwyd Bodelwyddan Denbighshire United Kingdom LL18 5UJ

Sponsors and Collaborators

  • Conor Martin
  • Betsi Cadwaladr University Health Board

Investigators

  • Principal Investigator: Sion Jones, MBBCh, BCUHB NHS

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Conor Martin, Dr Conor Martin, National Health Service, United Kingdom
ClinicalTrials.gov Identifier:
NCT02199782
Other Study ID Numbers:
  • BCUHB - PS - CAWS - 1
First Posted:
Jul 24, 2014
Last Update Posted:
Jul 24, 2014
Last Verified:
Jul 1, 2014
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 24, 2014